Published in Oncology Business Week, May 16th, 2004
Founded in 2003, Gloucester develops and commercializes innovative clinical and pre-investigational new drug application-stage products for the treatment of cancer. Apple Tree Partners, an early-stage, life sciences venture capital fund, provided the initial funding for the company.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Oncology Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.